M C Specht1, C B Barden, T J Fahey
1Department of Surgery, The New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, NY 10021, USA.
Mitogen-activated protein (MAP) kinase activation is common in papillary thyroid cancers (PTCs). Blocking this pathway with U0126 can inhibit thyroid cancer cell growth, suggesting it as a therapeutic target.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: